Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

PKM2 Mediates Chronic Myeloid Leukemia Imatinib Resistance By Regulating Glycolysis Energy Metabolism

Lin Tong, Na Xu, PhD, Xuan Zhou, PhD, Jixian Huang, Wu wan-Er, Chen Chen, Liu Liang, Qifa Liu, MD, Liu Xiaoli, MD

Blood (2018) 132 (Supplement 1): 1724.

https://doi.org/10.1182/blood-2018-99-113960

Published: 2018

Journal Articles

Efficacy of Early Convert to Dasatinib in Chronic Myeloid Leukemia Patients Who Inresponse or Intolerance to Imatinib

Liu Liang, Na Xu, PhD, Xuan Zhou, PhD, Huang JiXian, Chen Chen, Lin Tong, Wu wan-Er, Changxin Yin, Qifa Liu, MD, Liu Xiaoli, MD

Blood (2018) 132 (Supplement 1): 5430.

https://doi.org/10.1182/blood-2018-99-114120

Published: 2018

Journal Articles

The Clinical Characteristics and Efficacy of Chronic Myeloid Leukemia Patients with T315I Mutation

Chen Chen, Na Xu, PhD, Wu WanEr, Liu Liang, Xuan Zhou, PhD, Huang JiXian, Yin Changxin, Rui Cao, Qifa Liu, MD, Liu Xiaoli, MD

Blood (2018) 132 (Supplement 1): 5433.

https://doi.org/10.1182/blood-2018-99-114113

Published: 2018

Journal Articles

The Outcomes of Epstein-Barr Virus Specific T Cells from Different Sources for EBV Infections in Recipients of Allogeneic Stem Cell Transplantation

Ren Lin, Fen Huang, Zhiping Fan, Xiaoyan Shao, Guoxian Dai, Na Xu, PhD, Li Xuan, Jieyu Ye, Jing Sun, Qifa Liu, MD

Blood (2018) 132 (Supplement 1): 3330.

https://doi.org/10.1182/blood-2018-99-116010

Published: 2018

Journal Articles

Efficacy and Safety of Ruxolitinib in Treatment of Steroid Refractory/Refractory Acute Graft-Versus-Host Disease: A Prospective Multicenter Research

Zhiping Fan, MD, Lan Deng, MD PhD, Xudong Li, Qing Zhang, MD, Li Xuan, Fen Huang, Ren Lin, Hua Jin, Na Xu, PhD, Pengcheng Shi, Zhixiang Wang, PhD, Jieyu Ye, Ling Jiang, Jing Sun, Qifa Liu, MD

Blood (2018) 132 (Supplement 1): 5724.

https://doi.org/10.1182/blood-2018-99-117430

Published: 2018

Journal Articles

Corticosteroids Combined with Cyclosporine a Is Superior to Corticosteroids As First-Line Treatment for Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation

Weiran Lv, Hong Qu, Meiqing Wu, Zhiping Fan, MD, Fen Huang, Na Xu, PhD, Li Xuan, Ren Lin, Ke Zhao, Jing Sun, Yongrong Lai, MD, Yajing Xu, MD PhD, Qifa Liu, MD

Blood (2018) 132 (Supplement 1): 5736.

https://doi.org/10.1182/blood-2018-99-114043

Published: 2018

Journal Articles

Tumor-Associated Macrophages Maybe Associated with Acute Myeloid Leukemia Survival and Prognosis

Xuan Zhou, PhD, Na Xu, PhD, Xueyan Sun, Tong Lin, Zhiping Fan, Rui Cao, Qifa Liu, MD, Jing Sun, MD, Liu Xiaoli, MD

Blood (2017) 130 (Supplement 1): 5090.

https://doi.org/10.1182/blood.V130.Suppl_1.5090.5090

Published: 2017

Journal Articles

The Effect of Sorafenib Therapy on the Outcome of Acute Myeloid Leukemia with FLT3-ITD Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Li Xuan, Yu Wang, Fen Huang, Bingyi Wu, MD, Zhiping Fan, Na Xu, PhD, Jieyu Ye, Jing Sun, MD, Xiaojun Huang, Qifa Liu

Blood (2017) 130 (Supplement 1): 2045.

https://doi.org/10.1182/blood.V130.Suppl_1.2045.2045

Published: 2017

Journal Articles

Inhibition of Atg7 Enhances Mesenchymal Stem Cells Regulates Energy Metabolism Coupling to Overcome Drug Resistance in Chronic Myeloid Leukemia

Na Xu, PhD, Yangqing Lan, Ziyuan Lu, PhD, Xuan Zhou, PhD, Jixian Huang, Bolin He, Jing Sun, MD, Liu Xiaoli, MD

Blood (2017) 130 (Supplement 1): 5244.

https://doi.org/10.1182/blood.V130.Suppl_1.5244.5244

Published: 2017

Journal Articles

Tumor-Derived LOXL2 Is Highly Expressed in Myelofibrosis and Activating Mesenchymal Stem Cells Differentiate into Cancer Associated Fibroblasts In Vitro

Na Xu, PhD, Chengyun Pan, Xuan Zhou, PhD, Jixian Huang, Yangqing Lan, Bolin He, Jing Sun, MD, Liu Xiaoli, MD

Blood (2017) 130 (Supplement 1): 5289.

https://doi.org/10.1182/blood.V130.Suppl_1.5289.5289

Published: 2017

Journal Articles

Chidamide, a Novel Histone Deacetylase Inhibitor, Combined with Imatinib Induces Synthetic Lethality in Drug-Resistant Chronic Myeloid Leukemia

Bolin He, Qiang Wang, PhD, Na Xu, PhD, Ziyuan Lu, PhD, Chengyun Pan, Jing Sun, MD, Hongsheng Zhou, PhD, Liu Xiaoli, MD

Blood (2017) 130 (Supplement 1): 4990.

https://doi.org/10.1182/blood.V130.Suppl_1.4990.4990

Published: 2017

NARROW

PKM2 Mediates Chronic Myeloid Leukemia Imatinib Resistance By Regulating Glycolysis Energy Metabolism

Efficacy of Early Convert to Dasatinib in Chronic Myeloid Leukemia Patients Who Inresponse or Intolerance to Imatinib

The Clinical Characteristics and Efficacy of Chronic Myeloid Leukemia Patients with T315I Mutation

The Outcomes of Epstein-Barr Virus Specific T Cells from Different Sources for EBV Infections in Recipients of Allogeneic Stem Cell Transplantation

Efficacy and Safety of Ruxolitinib in Treatment of Steroid Refractory/Refractory Acute Graft-Versus-Host Disease: A Prospective Multicenter Research

Corticosteroids Combined with Cyclosporine a Is Superior to Corticosteroids As First-Line Treatment for Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation

Tumor-Associated Macrophages Maybe Associated with Acute Myeloid Leukemia Survival and Prognosis

The Effect of Sorafenib Therapy on the Outcome of Acute Myeloid Leukemia with FLT3-ITD Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Inhibition of Atg7 Enhances Mesenchymal Stem Cells Regulates Energy Metabolism Coupling to Overcome Drug Resistance in Chronic Myeloid Leukemia

Tumor-Derived LOXL2 Is Highly Expressed in Myelofibrosis and Activating Mesenchymal Stem Cells Differentiate into Cancer Associated Fibroblasts In Vitro

Chidamide, a Novel Histone Deacetylase Inhibitor, Combined with Imatinib Induces Synthetic Lethality in Drug-Resistant Chronic Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only